CHO Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	168.87	21.81	203.79	505.66	777.98	986.39
Short-Term Investments	2,058	2,344	2,399	538.9	538.9	538.9
Cash & Short-Term Investments	2,227	2,366	2,603	1,045	1,317	1,525
Cash Growth	-10.56%	-9.10%	149.17%	-20.68%	-13.66%	-15.42%
Accounts Receivable	0.1	0.75	-	-	0.06	-
Other Receivables	6.24	5.05	2.09	0.09	0.08	0.09
Receivables	6.34	5.8	2.09	0.09	0.14	0.09
Other Current Assets	54.36	45.68	38.23	34.8	23.62	21.29
Total Current Assets	2,288	2,417	2,643	1,079	1,341	1,547
Property, Plant & Equipment	30.27	36.43	8.2	19.74	37.23	62.51
Other Intangible Assets	421.3	424.8	431.8	497.23	509.93	528.63
Other Long-Term Assets	3.43	2.67	3.02	5.84	5.91	5.15
Total Assets	2,743	2,881	3,086	1,602	1,894	2,143
Accrued Expenses	76.28	95.75	99.43	150.85	113.04	130.38
Current Portion of Leases	14.45	14.31	-	11.7	13.87	12.59
Other Current Liabilities	8.45	6.12	6.6	6.35	6.31	6.23
Total Current Liabilities	104.7	116.19	106.03	168.9	133.22	149.2
Long-Term Leases	7.33	14.59	-	-	11.7	25.67
Other Long-Term Liabilities	-	1.8	4.8	4.8	4.8	4.8
Total Liabilities	112.03	132.58	110.83	173.7	149.71	179.67
Common Stock	2,140	2,140	2,140	1,840	1,839	1,838
Additional Paid-In Capital	823.54	1,130	1,688	135.73	410.58	782.73
Retained Earnings	-330.35	-518.31	-850.41	-544.32	-502.76	-655.21
Comprehensive Income & Other	-2.76	-2.7	-2.75	-2.79	-3.25	-2.53
Shareholders' Equity	2,631	2,749	2,975	1,429	1,744	1,963
Total Liabilities & Equity	2,743	2,881	3,086	1,602	1,894	2,143
Total Debt	21.78	28.9	-	11.7	25.56	38.26
Net Cash (Debt)	2,205	2,337	2,603	1,033	1,291	1,487
Net Cash Growth	-10.13%	-10.21%	151.99%	-20.02%	-13.16%	-15.65%
Net Cash Per Share	10.30	10.92	13.60	5.61	7.02	8.10
Filing Date Shares Outstanding	214.01	214.01	214.01	183.99	183.94	183.68
Total Common Shares Outstanding	214.01	214.01	214.01	183.99	183.94	183.68
Working Capital	2,183	2,301	2,537	910.56	1,207	1,397
Book Value Per Share	12.29	12.84	13.90	7.76	9.48	10.69
Tangible Book Value	2,209	2,324	2,543	931.34	1,234	1,435
Tangible Book Value Per Share	10.32	10.86	11.88	5.06	6.71	7.81
Machinery	115.41	112.08	107.99	104.61	96.59	95.3
Leasehold Improvements	20.46	20.72	20.38	19.82	18.6	18.66

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.